Find a Pediatric Clinical Trial

Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our list of clinical trials that are currently enrolling new pediatric patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

Showing 41 - 60 of 89 trials
Title Investigatorsort icon Disease(s)
A Phase I Study of Intrathecal Radioimmunotherapy Using 131I-8H9 for Central Nervous System/Leptomeningeal Cancers
[Protocol 03-133]
Kramer, Kim
  • Brain Tumors, Primary
  • Neuroblastoma
  • Pediatric Brain Tumors
    • Brain Cancer
    • CNS Cancer
A Phase II Study of Intrathecal I131-3F8 in Patients with GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms
[Protocol 05-122]
Kramer, Kim
  • Brain Tumors, Metastatic
  • Brain Tumors, Primary
    • Brain Metastases
  • Neuroblastoma
  • Pediatric Brain Tumors
    • Brain Cancer
    • CNS Cancer
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in the Bone Marrow
[Protocol 09-161]
Kushner, Brian
  • Neuroblastoma
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma
[Protocol 09-160]
Kushner, Brian
  • Neuroblastoma
A Phase I Study of the Hu3F8 Antibody plus GM-CSF in Patients with Relapsed/Refractory Neuroblastoma
[Protocol 12-230]
Kushner, Brian
  • Neuroblastoma
A Phase I Trial of a Trivalent Vaccine with Escalating Doses of the Immunological Adjuvant OPT-821 Plus Oral ß-Glucan for High-Risk Neuroblastoma
[Protocol 05-075]
Kushner, Brian
  • Neuroblastoma
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission after Non-Myeloablative Therapy in Patients with High-Risk Neuroblastoma
[Protocol 09-159]
Kushner, Brian
  • Neuroblastoma
A Pilot Trial of Irinotecan, Temozolomide, and Bevacizumab plus High-Dose Chemotherapy for Newly Diagnosed Patients with Desmoplastic Small Round Cell Tumor
[Protocol 10-091]
Magnan, Heather
  • Sarcomas
    • Soft Tissue Sarcoma
Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Cancer and Bone Marrow Transplantation Patients
[Protocol 03-123]
Meyers, Paul
  • Hematology
    • Hematologic Malignancies
  • Sarcomas
A Phase I Study of Panitumumab in Children with Solid Tumors
[Protocol 08-020]
Meyers, Paul
A Phase I Study of Intraperitoneal Radioimmunotherapy with 131I-8H9 for Patients with Desmoplastic Small Round Cell Tumors and Other Solid Peritoneal Tumors
[Protocol 09-090]
Modak, Shakeel
A Pilot Phase II Study of Targeted Radiotherapy with 131I-MIBG and Arsenic Trioxide in Patients with Resistant Neuroblastoma or Malignant Chromaffin Cell Tumors
[Protocol 04-148]
Modak, Shakeel
  • Neuroblastoma
A Phase II Study of Bevacizumab, Irinotecan, and Temozolomide for Relapsed or Refractory Neuroblastoma
[Protocol 10-015]
Modak, Shakeel
  • Neuroblastoma
A Phase I Study of Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
[Protocol 09-011]
Modak, Shakeel
  • Neuroblastoma
Brentuximab (SGN-35) in Transplant-Eligible Patients with Relapsed or Refractory Hodgkin Lymphoma
[Protocol 11-142]
Moskowitz, Alison
  • Lymphoma
    • Hodgkin's Disease
High-Dose Chemotherapy with Autologous Stem Cell Rescue for Aggressive B-Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients
[Protocol 10-181]
Noy, Ariela
  • AIDS-Associated Cancers
    • AIDS-Associated Lymphomas
  • Blood & Marrow Stem Cell Transplantation
    • Autologous
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase II Study of CMV-Immune T cells for the Treatment of Cytomegalovirus Infection after Stem Cell Transplantation
[Protocol 12-086]
O'Reilly, Richard
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
A Phase I/II Study of the Toxic and Therapeutic Effects of T Cells in the Treatment of Epstein Barr Virus-Associated Lymphoproliferative Disorders
[Protocol 95-024]
O'Reilly, Richard
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
  • Blood and Marrow Transplantation
    • Transplantation
  • Leukemia
  • Lymphoma
A Prospective Natural History Study of the Diagnosis, Treatment, and Outcomes of Children with SCID Disorders
[Protocol 10-150]
O'Reilly, Richard
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Hematologic Disorders
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation
[Protocol 07-055]
O'Reilly, Richard
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Myelodysplastic Syndrome